CODA Genomics Closes Series A

Irvine-based CODA Genomics said this morning that it has closed a Series A round of funding from the Tech Coast Angels. The company received $800,000 from the TCA, and has added TCA members Jay S. Kunin, Ph.D. and Robert Engler, MD to its board of directors. CODA is commercializing DNA assembly and protein expression technology, and is based on research from UC Irvine. The company's products are used for research on protein structure and function. More information »